Immunohistochemical analysis of tumor sections revealed enhanced expression of Ki67 in CM of Act RAW264.7 treated tumor which was inhibited after neutralization of IL-6 suggesting that TAM derived IL-6 induced cell proliferation in breast cancer (Fig. 6F). Here, IL6 is linked to neoplasm.